Method of administration: Auricular (otic), Oral, Intravenous, Ophthalmic, Topical, Intratympanic
FDA approval date: October 22, 1987
Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections ( Error! Hyperlink reference not valid. ), Bone and Joint Infections.